China’s industrial profits grow at fastest in eight months, but sustained recovery uncertain
December 27, 2019Oil hits three-month highs as strong U.S. consumer spending underpins growth hopes
December 27, 2019Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
at
Astellas Pharma Inc has bought U.S.-based Xyphos Biosciences Inc to expand its immuno-oncology business, a deal worth up to $665 million including potential development milestones and its second acquisition announced this month.
Powered by WPeMatico
